SR11237 (BMS-649)是一种选择性的视黄酸 X 受体 (RXR) 激动剂,无视黄酸受体 (RAR) 活性。它诱导 RXR/RXR 同源二聚体的形成,并激活含 RXR 响应元件的报告基因。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | SR11237, also known as BMS-649, is a potent, selective retinoid X receptor (RXR) agonist with no RAR activity. SR11237 results in the formation of RXR/RXR homodimers and transactivation of reporter genes containing RXR response elements[1][2][3]. |
Animal study | Administered intraperitoneally at a dose of 25 mg/kg and daily on postnatal days 5 to 15, SR11237 causes irregular ossification and premature closure of the growth plate, including disturbances in ossification and bone morphology, including premature closure of the growth plate and infiltration of ossified tissue into the central epiphysis in postnatal Sprague-Dawley rats.]2]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.63mL 0.53mL 0.26mL |
13.14mL 2.63mL 1.31mL |
26.28mL 5.26mL 2.63mL |
CAS号 | 146670-40-8 |
分子式 | C24H28O4 |
分子量 | 380.477 |
别名 | BMS-649 |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Sealed in dry,2-8°C |
溶解度 |
DMSO: 4 mg/mL(10.51 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |